Eight new stocks make our Dividend Growth Stocks Model Portfolio this month, which was made available to members on May 30, 2019.
The long-term success of our model portfolio strategies highlights the value of our Robo-Analyst technology, which scales our forensic accounting expertise (featured in Barron’s) across thousands of stocks.
The methodology for this model portfolio mimics an All-Cap Blend style with a focus on dividend growth. Selected stocks earn an Attractive or Very Attractive rating, generate positive free cash flow (FCF) and economic earnings, offer a current dividend yield >1%, and have a 5+ year track record of consecutive dividend growth. This model portfolio is designed for investors who are more focused on long-term capital appreciation than current income, but still appreciate the power of dividends, especially growing dividends.
Featured Stock from May: Gentex Corporation (GNTX: $22/share)
Since 2009, GNTX has grown revenue by 13% compounded annually and after-tax profit (NOPAT) by 19% compounded annually. Over the same time, NOPAT margin improved from 12% in 2009 to 21% TTM while its return on invested capital (ROIC) improved from 18% to 25%.
Figure 1: GNTX’s Revenue & NOPAT Since 2009
New Constructs, LLC and company filings
Steady Dividend Growth Supported by FCF
Gentex has increased its annual dividend each of the past nine years. GTNX’s annual dividend has grown 8% compounded annually over the past five years, from $0.31/share in 2014 to $0.46/share in 2019. Most importantly, GNTX easily generates the cash flow needed to continue paying and growing its dividend. Over the past five years, GNTX has generated a cumulative $1.5 billion in FCF (27% of market cap) while paying $511 million in dividends.
Companies with FCF well in excess of dividend payments provide higher quality dividend growth opportunities because we know the firm generates the cash to support a higher dividend. On the other hand, the dividend of a company where FCF falls short of the dividend payment over time cannot be trusted to grow or even stay the same because of inadequate free cash flow.
Figure 2: Free Cash Flow (FCF) vs. Regular Dividend Payments
Sources: New Constructs, LLC and company filings
GNTX Holds Significant Upside Potential
At its current price of $22/share, GNTX has a price-to-economic book value (PEBV) ratio of 1.0. This ratio means the market expects GNTX’s NOPAT never to grow from current levels. This expectation seems rather pessimistic for a firm that has grown NOPAT by 19% compounded annually since 2009 and 12% compounded annually over the past two decades.
If GNTX can maintain 2018 margins (21%) and grow NOPAT by just 4% compounded annually for the next decade, the stock is worth $28/share today – a 27% upside. See the math behind this dynamic DCF scenario. Add in Gentex’s 2.1% dividend yield and history of dividend growth, and it’s clear why this stock is in May’s Dividend Growth Stocks Model Portfolio.
Critical Details Found in Financial Filings by Our Robo-Analyst Technology
As investors focus more on fundamental research, research automation technology is needed to analyze all the critical financial details in financial filings. Below are specifics on the adjustments we make based on Robo-Analyst findings in Gentex Corporation’s 2018 10-K:
Balance Sheet: we made $568 million of adjustments to calculate invested capital with a net decrease of $408 million. The most notable adjustment was $67 million (3% of reported net assets) related to asset write-downs. See all adjustments to GNTX’s balance sheet here.
Valuation: we made $585 million of adjustments with a net effect of increasing shareholder value by $399 million. The largest adjustment to shareholder value was $492 million in excess cash. This adjustment represents 9% of GNTX’s market value. See all adjustments to GNTX’s valuation here.
This article originally published on June 6, 2019.
Disclosure: David Trainer and Kyle Guske II receive no compensation to write about any specific stock, style, or theme.
 Harvard Business School features the powerful impact of our research automation technology in the case New Constructs: Disrupting Fundamental Analysis with Robo-Analysts.